Patent details

Basic Information

Publication number:

EP2402319

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111582243

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DGAT Inhibitors

French Title of Invention:

Inhibiteurs de la DGAT

German Title of Invention:

DGAT Inhibitoren

SPC Number:

Dates

Filing date:

28/03/2007

Grant date:

30/08/2017

EP Publication Date:

04/01/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/08/2017

EP B1 Publication Date:

30/08/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/03/2018

Expiration date:

28/03/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

30/08/2017

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Serrano-Wu, Michael H

Address:

United States (US)

2

Name:

Liu, Wenming

Address:

United States (US)

3

Name:

Kwak, Young-Shin

Address:

United States (US)

Priority

Priority Number:

787859 P

Priority Date:

31/03/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/421; A61K 31/426; A61K 31/44; A61K 31/50; A61K 31/53; C07D 213/74; C07D 213/75; C07D 213/81; C07D 213/82; C07D 237/20; C07D 239/42; C07D 263/48; C07D 277/42; C07D 401/10; C07D 401/12; C07D 401/14; C07D 405/12; C07D 413/10; C07D 413/12;

Publication

European Patent Bulletin

Issue number:

201735

Publication date:

30/08/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1